-

Information on the Compensation of Mr Guillaume Pepy as Chairman of the Board of Directors of ORPEA

PUTEAUX, France--(BUSINESS WIRE)--Regulatory News:

ORPEA (Paris:ORP):

Mr Guillaume Pepy was appointed Chairman of the Board of Directors following the General Meeting of July 28, 2022, during which he was appointed as an independent director.

In accordance with the remuneration policy applicable to the Chairman of the Board of Directors for the year 2022, approved by the General Meeting held today, the Board of Directors, during its meeting held on the same day, set the components of his remuneration as follows.

Mr Guillaume Pepy will receive a fixed annual remuneration of 260,000 euros. This remuneration is effective as of today and will be paid on a pro rata basis.

He also receives compensation for his duties as a director, calculated in accordance with the terms of the Directors' remuneration policy for the year 2022 approved by the abovementioned Meeting.

He does not receive any variable annual or exceptional bonus payments, nor any other element of compensation (including stock options or performance shares) or any benefit in kind.

About ORPEA (www.orpea-corp.com)

ORPEA is a leading global player, expert in the care of all types of frailty. The Group operates in 22 countries and covers three core businesses: care for the elderly (nursing homes, assisted living, home care), post-acute and rehabilitation care and mental health care (specialized clinics). It has more than 71,000 employees and welcomes more than 255,000 patients and residents each year.

ORPEA is listed on Euronext Paris (ISIN code: FR0000184798) and is a member of the SBF 120, STOXX 600 Europe, MSCI Small Cap Europe and CAC Mid 60 indices.

Contacts

Investor Relations
ORPEA
Benoit Lesieur
Investor Relations Director
b.lesieur@orpea.net

Investor Relations
NewCap
Dusan Oresansky
Tel.: +33 (0)1 44 71 94 94
ORPEA@newcap.eu

Media Relations
Image 7
Charlotte Le Barbier
Tel.: +33 (0)6 78 37 27 60
clebarbier@image7.fr

Laurence Heilbronn
Tel.: +33 (0)6 89 87 61 37
lheilbronn@image7.fr

ORPEA

BOURSE:ORP

Release Versions

Contacts

Investor Relations
ORPEA
Benoit Lesieur
Investor Relations Director
b.lesieur@orpea.net

Investor Relations
NewCap
Dusan Oresansky
Tel.: +33 (0)1 44 71 94 94
ORPEA@newcap.eu

Media Relations
Image 7
Charlotte Le Barbier
Tel.: +33 (0)6 78 37 27 60
clebarbier@image7.fr

Laurence Heilbronn
Tel.: +33 (0)6 89 87 61 37
lheilbronn@image7.fr

More News From ORPEA

emeis: Revenue and Business Performance as of the End of September 2026

PUTEAUX, France--(BUSINESS WIRE)--Regulatory News: emeis (Paris:EMEIS): Strong business activity across all of the Group’s markets Strong like-for-like revenue growth of +6.0% as of the end of September 60% from international operations, up +7.8% 40% in France, up +3.6% Like-for-like revenue growth driven across all regions by improved occupancy rates, a favorable pricing effect, and the ramp-up of recently opened facilities. Business was primarily driven by nursing homes (66% of revenue), whic...

emeis completes the disposal of all its operations in Latin America

PUTEAUX, France--(BUSINESS WIRE)--Regulatory News: Following the completion of the sale of its Brazilian operations, emeis (Paris:EMEIS) has finalized the divestment of all its operating activities in Latin America, for a total amount of approximately €111m1. This transaction marks an important milestone in the Group's strategic repositioning towards its core European markets, while further strengthening its financial structure. In 2024, the Group launched a disposal plan aimed at progressively...

emeis: Availability of the 2026 Half-Year Financial Report

PUTEAUX, France--(BUSINESS WIRE)--Regulatory News: emeis (Paris:EMEIS):  emeis filed, today, its half-year financial report for the period starting on 1 January 2026 and ending on 30 June 2026, with the French Autorité des Marchés Financiers. The half-year report can be consulted and downloaded from the Company’s website at: https://www.emeis.com/en/investors-shareholders/financial-information-and-publications/universal-registration-document. It is also available at the Company’s headquarter (e...
Back to Newsroom